Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Effects of heme degradation products on reactivation of latent HIV-1.

Shankaran P, Madlenakova M, Hajkova V, Jilich D, Svobodova I, Horinek A, Fujikura Y, Melkova Z.

Acta Virol. 2017;61(1):86-96. doi: 10.4149/av_2017_01_86.

PMID:
28161963
2.

Current views on HIV-1 latency, persistence, and cure.

Melkova Z, Shankaran P, Madlenakova M, Bodor J.

Folia Microbiol (Praha). 2017 Jan;62(1):73-87. doi: 10.1007/s12223-016-0474-7. Epub 2016 Oct 5. Review.

PMID:
27709447
3.

Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.

Shankaran P, Vlkova L, Liskova J, Melkova Z.

Antiviral Res. 2011 Dec;92(3):434-46. doi: 10.1016/j.antiviral.2011.09.011. Epub 2011 Oct 5.

5.

Immunoassay of triiodothyronine in serum by time-resolved fluorometric measurement of europium-chelate complexes in solution.

Papanastasiou-Diamandi A, Shankaran P, Khosravi MJ.

Clin Biochem. 1992 Aug;25(4):255-61.

PMID:
1525981
6.

Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry.

Shankaran P, Reichstein E, Khosravi MJ, Diamandis EP.

J Clin Microbiol. 1990 Mar;28(3):573-9.

7.

Phosphatidylcholine and 4-methylumbelliferyl phosphorylcholine hydrolysis by purified placental sphingomyelinase.

Freeman SJ, Shankaran P, Wolfe LS, Callahan JW.

Can J Biochem Cell Biol. 1985 Apr;63(4):272-7.

PMID:
2990645
8.
9.

Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.

Poulos A, Ranieri E, Shankaran P, Callahan JW.

Biochim Biophys Acta. 1984 Apr 18;793(2):141-8.

PMID:
6712963
10.

Monoclonal antibodies against human placental sphingomyelinase.

Freeman SJ, Davidson DJ, Shankaran P, Callahan JW.

Biosci Rep. 1983 Jun;3(6):545-50.

PMID:
12033401
11.

Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease.

Poulos A, Shankaran P, Jones CS, Callahan JW.

Biochim Biophys Acta. 1983 May 16;751(3):428-31.

PMID:
6303435
12.

Studies on the structure of sphingomyelinase. Amino acid composition and heterogeneity on isoelectric focusing.

Jones CS, Shankaran P, Davidson DJ, Poulos A, Callahan JW.

Biochem J. 1983 Feb 1;209(2):291-7.

13.

The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups.

Callahan JW, Jones CS, Davidson DJ, Shankaran P.

J Neurosci Res. 1983;10(2):151-63.

PMID:
6313952
14.

Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography.

Jones CS, Shankaran P, Callahan JW.

Biochem J. 1981 May 1;195(2):373-82.

15.

Studies on the hydrophobic properties of sphingomyelinase.

Callahan JW, Gerrie J, Jones CS, Shankaran P.

Biochem J. 1981 Jan 1;193(1):275-83.

16.

Sphingomyelinases in human tissues. IV. Purification of sphingomyelinase from human placenta and effect of Triton X-100.

Callahan JW, Shankaran P, Khalil M, Gerrie J.

Can J Biochem. 1978 Sep;56(9):885-91.

PMID:
215291
17.

Biochemical changes in liver due to aflatoxin.

Shankaran P, Shankaran R, Raj HG, Venkitasubramanian TA.

Br J Exp Pathol. 1970 Oct;51(5):487-91. No abstract available.

18.

HEALING OF EXPERIMENTAL WOUNDS WITH HELIANTHUS ANNUS.

DESHPANDE PJ, PATHAK SN, SHANKARAN PS.

Indian J Med Res. 1965 Jun;53:539-44. No abstract available.

PMID:
14344963
19.

TRANSPLANTATION OF PANCREAS IN DOGS.

MATHUR MM, TEWARI SP, SHANKARAN PS.

Indian J Med Res. 1964 Oct;52:1080-3. No abstract available.

PMID:
14252237
20.

Reduplication of the male urethra.

LAKHTAKIA HS, DESHPANDEY PJ, SHANKARAN PS.

Br J Urol. 1962 Jun;34:224-6. No abstract available.

PMID:
14461656

Supplemental Content

Loading ...
Support Center